Neuronetics
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 203
- Market Cap
- -
- Introduction
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.
Retrospective Analyses of TrakStar Database
- Conditions
- DepressionAnxiety DepressionObsessive-Compulsive Disorder
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 156000
- Registration Number
- NCT06917339
- Locations
- 🇺🇸
Neuronetics, Malvern, Pennsylvania, United States
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
- Conditions
- MDD
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 7690
- Registration Number
- NCT06699940
- Locations
- 🇺🇸
Neuronetics, Malvern, Pennsylvania, United States
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
- Conditions
- Neurologic Symptoms
- Interventions
- Device: rTMS
- First Posted Date
- 2024-05-28
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 20
- Registration Number
- NCT06429748
- Locations
- 🇺🇸
Charlotte Skin and Laser, Charlotte, North Carolina, United States
Retrospective TMS Therapy for Adults With MDD
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Device: TMS
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 6456
- Registration Number
- NCT05541302
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
- Conditions
- Major Depressive Disorder
- Interventions
- Device: repetitive Transcranial Magnetic Stimulation
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 40
- Registration Number
- NCT05535062
- Locations
- 🇺🇸
TMS of South Tampa, Tampa, Florida, United States
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Transcranial Magnetic Stimulator
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Neuronetics
- Registration Number
- NCT04217837
- Locations
- 🇬🇧
St Pancras Hospital, London, United Kingdom
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Sham NeuroStar® Transcranial Magnetic Stimulation (TMS)Device: Open Label Active NeuroStar® TMSDevice: Active NeuroStar® Transcranial Magnetic Stimulation (TMS)
- First Posted Date
- 2015-10-26
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 100
- Registration Number
- NCT02586688
- Locations
- 🇺🇸
Florida Clinical Practice Association, Inc., Gainesville, Florida, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸Anchor Neuroscience, Pensacola, Florida, United States
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
- Conditions
- Depression, Postpartum
- Interventions
- Device: NeuroStar Transcranial Magnetic Stimulation (TMS)
- First Posted Date
- 2013-04-29
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 25
- Registration Number
- NCT01842542
- Locations
- 🇺🇸
Hartford Hospital Institute of Living, Hartford, Connecticut, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸TMS Center of Lehigh Valley, Allentown, Pennsylvania, United States
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- Device: NeuroStar TMS
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 67
- Registration Number
- NCT01415154
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Premier Psychiatric Group, L.L.C., Lincoln, Nebraska, United States
🇺🇸Sheppard Pratt Health System, Baltimore, Maryland, United States
NeuroStar TMS Therapy System: Utilization and Outcomes
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2015-11-13
- Lead Sponsor
- Neuronetics
- Target Recruit Count
- 307
- Registration Number
- NCT01114477
- Locations
- 🇺🇸
Lee Ann Kelley, M.D., PC, Phoenix, Arizona, United States
🇺🇸Sacramento TMS, El Dorado Hills, California, United States
🇺🇸Todd Hutton, MD & Associates, Pasadena, California, United States